Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

<p>Supplementary Table S8</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Laura E. Stevens (14961009) (author)
Andere auteurs:	Guillermo Peluffo (14961012) (author), Xintao Qiu (14958882) (author), Daniel Temko (14961015) (author), Anne Fassl (14961018) (author), Zheqi Li (14961021) (author), Anne Trinh (14961024) (author), Marco Seehawer (14961027) (author), Bojana Jovanović (14961030) (author), Maša Alečković (14961033) (author), Callahan M. Wilde (14961036) (author), Renee C. Geck (14961039) (author), Shaokun Shu (14961042) (author), Natalie L. Kingston (14961045) (author), Nicholas W. Harper (14937782) (author), Vanessa Almendro (14961048) (author), Alanna L. Pyke (14961051) (author), Shawn B. Egri (14961054) (author), Malvina Papanastasiou (14961057) (author), Kendell Clement (14961060) (author), Ningxuan Zhou (14961063) (author), Sarah Walker (14961066) (author), Jacqueline Salas (14961069) (author), So Yeon Park (14961072) (author), David A. Frank (14961075) (author), Alexander Meissner (14961078) (author), Jacob D. Jaffe (14961081) (author), Piotr Sicinski (14961084) (author), Alex Toker (14961087) (author), Franziska Michor (14961090) (author), Henry W. Long (14947498) (author), Beth A. Overmoyer (14961093) (author), Kornelia Polyak (14961096) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Tumor Biology Therapeutic Research and Development Breast Cancer Drug Resistance Tumor Heterogeneity
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
door: Laura E. Stevens (14961009)
Gepubliceerd in: (2025)

Supplementary Table 8_Genes identified by classification analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 3_Clonal distribution analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 10_Pro metastatic pathways identified by classification analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 1_Primer and shRNA sequences_PCR cycles_Mycoplasma testing from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 2_Predictive power of genes and signatures_Patient cohorts GEO accession number from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 4_Marker genes all and some per cluster_GO and curated pathways per cluster from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Table 5_Marker genes all and some per cluster no cell cycle_GO and curated pathways per cluster no cell cycle from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
door: Junko Tsuji (15051410)
Gepubliceerd in: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
door: Laura Privitera (16015972)
Gepubliceerd in: (2025)

Supplementary File 1 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
door: Rania Bassiouni (14963190)
Gepubliceerd in: (2025)

Supplementary File 2 from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
door: Rania Bassiouni (14963190)
Gepubliceerd in: (2025)

Figure S1 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
door: Alexander J. Cole (14971167)
Gepubliceerd in: (2025)

Figure S2 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
door: Alexander J. Cole (14971167)
Gepubliceerd in: (2025)

Figure S3 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
door: Alexander J. Cole (14971167)
Gepubliceerd in: (2025)

Figure S4 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
door: Alexander J. Cole (14971167)
Gepubliceerd in: (2025)

Figure S5 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
door: Alexander J. Cole (14971167)
Gepubliceerd in: (2025)

Supplementary Tables S1-S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
door: Axel Stenmark Tullberg (15029928)
Gepubliceerd in: (2025)

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplementary Figure 8 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
door: Patrizia Mondello (15045002)
Gepubliceerd in: (2025)

Image 2_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
door: Yini Wang (410389)
Gepubliceerd in: (2025)

Image 1_Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation.tiff
door: Yini Wang (410389)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_5cu71cr02tgo80oap8shs86huu